UNSPSC 51151611: Glycopyrrolate

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51151611

Definition

This classification denotes an antimuscarinic agent with the molecular formula C19H28NO3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier A14FB57V1D, chemically known as 3-hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate but more generally known as glycopyrrolate, which bears U.S. National Institutes of Health Compound Identifier 3494. The European Medicines Agency schedules Glycopyrronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02381MIG.

Read the full definition

The term GLYCOPYRRONIUM BROMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). The World Health Organization schedules glycopyrrolate in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.

About UNSPSC 51151611

UNSPSC 51151611 Glycopyrrolate is a Commodity code that nominally names a specific pharmaceutical agent, but the recent state and local opportunities posted under this code do not align with glycopyrrolate procurement — instead, they reflect broader pharmaceutical and pharmacy-benefit sourcing activity. Seminole County, Florida has solicited naloxone and drug deactivation systems through an IFB, while the Texas Health and Human Services Commission issued an RFI to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The mismatch between the code name and the actual work being bought suggests either a tagging error in these opportunities or significant scope drift in how state and local procurement offices are using this code. The issuing bodies span both county-level health departments and state-level health and human services agencies, indicating multi-tier government involvement in pharmaceutical sourcing and management.

Geographically, the recent activity clusters in Texas and Florida. The Seminole County opportunity (IFB 60459723LAS) closes July 26, 2023, with quarterly deliveries of naloxone and deactivation systems to the county's community health building in Sanford, Florida, and the Texas HHS RFI (HHS0017013) posted April 3, 2026, seeks vendor capabilities for direct-to-manufacturer prescription fulfillment. Given the timing mismatch in the Seminole County record (posted June 30, 2026, but listing a 2023 close date) and the exploratory nature of the Texas RFI, this code shows limited recent, clearly relevant procurement activity. Vendors pursuing work under this code should verify the actual scope before bid preparation, as the nominal code definition appears disconnected from the opportunities currently being solicited.

Quick answers

What is UNSPSC 51151611?

UNSPSC 51151611 is Glycopyrrolate, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51151611?

UNSPSC 51151611 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51151611

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code